Tectonic Therapeutic (TECX) Invested Capital (2021 - 2023)

Tectonic Therapeutic (TECX) has reported Invested Capital for 4 consecutive years, with $1.1 million the latest figure, recorded in Q2 2024.

• In Q2 2024, Invested Capital changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2025 stood at $1.1 million (changed N/A YoY), while the FY2022 annual figure was $16.3 million, changed 0.0% from the prior year.
• Invested Capital retreated to $1.1 million in Q2 2024 per TECX's latest filing, from $16.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $16.3 million in Q4 2021 and bottomed at $1.1 million in Q2 2024.
• Historically, Invested Capital has averaged $14.2 million across 4 years, with a median of $16.3 million in 2021.
• On a YoY basis, Invested Capital climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Tectonic Therapeutic's Invested Capital stood at $16.3 million in 2021, then changed by 0.0% to $16.3 million in 2022, then changed by 0.0% to $16.3 million in 2023, then tumbled by 93.2% to $1.1 million in 2024.
• Business Quant data shows TECX's Invested Capital at $1.1 million in Q2 2024, $16.3 million in Q1 2023, and $16.3 million in Q4 2022.